Stocktoria
UPEXI, INC. UPXI
UPEXI, INC. (UPXI) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the grey zone. It does not currently pay a dividend. FY2025 revenue was $15.8M at a -86.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.45 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.196 |
| Retained earnings / assets | -0.489 |
| EBIT / assets | -0.101 |
| Equity / liabilities | 2.673 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| UPXI | UPEXI, INC. | 4/9 | 1.82 | — | -39.2% |
| NCTY | The9 LTD | 2/9 | — | — | +0.8% |
| VRME | VerifyMe, Inc. | 4/9 | -16.73 | — | -32.3% |
| BTCS | BTCS Inc. | 1/9 | — | — | — |
| BTCT | BTC Digital Ltd. | 2/9 | -0.73 | — | +20.3% |
| TONX | TON Strategy Co | 3/9 | — | — | — |
| JFU | 9F Inc. | 6/9 | — | — | +12.2% |
All Finance, Insurance & Real Estate companies →
About UPEXI, INC.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.
FAQ
Is UPXI financially healthy?
UPEXI, INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does UPXI pay a dividend?
No, UPEXI, INC. does not currently pay a dividend.
How profitable is UPXI?
In FY2025, UPEXI, INC. had a net margin of -86.5% and a return on equity of -15.2%.
What is the analyst price target for UPXI?
The average Wall-Street price target for UPEXI, INC. is $5.00, about 507.1% above the recent price, from 2 analysts.
Is UPXI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on UPEXI, INC.: a Piotroski F-score of 4/9, an Altman Z″ in the grey zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.